Search research articles
Contact Us
Filters
Showing results (111-120 of 119) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 119 results.
Anti-Cancer Drug Design
|
June 2, 2000
Synthesis and antitumor activities of amino acid prodrugs of amino-combretastatins
K Ohsumi, T Hatanaka, R Nakagawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 24, 2001
[Enteral nutrition for gastrointestinal disease in home care]
S Iijima, M Horiuchi, T Higuchi, et al.
Journal of Biochemistry
|
October 1, 1993
Interaction of subtilisin BPN' and recombinant Streptomyces subtilisin inhibitors with substituted P1 site residues
K Masuda-Momma, T Hatanaka, K Inouye, et al.
American Journal of Physiology. Cell Physiology
|
November 8, 2001
Cloning and functional characterization of a new subtype of the amino acid transport system N
T Nakanishi, R Kekuda, Y J Fei, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 15, 2002
[The new portable system for home enteral nutrition, Portermate, made a patient possible go out for a long time: report of a case]
S Iijima, T Kai, K Iwade, et al.
Acta Gastro-Enterologica Belgica
|
February 28, 2021
A change in the timing for starting systemic therapies for hepatocellular carcinoma: the comparison of sorafenib and lenvatinib as the first-line treatment
T Hatanaka, S Kakizaki, T Nagashima, et al.
Japanese Journal of Cancer Research : Gann
|
November 7, 1999
A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors
Y Nihei, Y Suga, Y Morinaga, et al.
Acta Gastro-Enterologica Belgica
|
February 28, 2021
Tolvaptan reduces the required amount of albumin infusion in patients with decompensated cirrhosis with uncontrolled ascites : a multicenter retrospective propensity score-matched cohort study
Y Suzuki, A Naganuma, T Hoshino, et al.
ESMO Open
|
October 8, 2022
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis
M Rimini, L Rimassa, K Ueshima, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 119) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 119 results.
Anti-Cancer Drug Design
|
June 2, 2000
Synthesis and antitumor activities of amino acid prodrugs of amino-combretastatins
K Ohsumi, T Hatanaka, R Nakagawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 24, 2001
[Enteral nutrition for gastrointestinal disease in home care]
S Iijima, M Horiuchi, T Higuchi, et al.
Journal of Biochemistry
|
October 1, 1993
Interaction of subtilisin BPN' and recombinant Streptomyces subtilisin inhibitors with substituted P1 site residues
K Masuda-Momma, T Hatanaka, K Inouye, et al.
American Journal of Physiology. Cell Physiology
|
November 8, 2001
Cloning and functional characterization of a new subtype of the amino acid transport system N
T Nakanishi, R Kekuda, Y J Fei, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 15, 2002
[The new portable system for home enteral nutrition, Portermate, made a patient possible go out for a long time: report of a case]
S Iijima, T Kai, K Iwade, et al.
Acta Gastro-Enterologica Belgica
|
February 28, 2021
A change in the timing for starting systemic therapies for hepatocellular carcinoma: the comparison of sorafenib and lenvatinib as the first-line treatment
T Hatanaka, S Kakizaki, T Nagashima, et al.
Japanese Journal of Cancer Research : Gann
|
November 7, 1999
A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors
Y Nihei, Y Suga, Y Morinaga, et al.
Acta Gastro-Enterologica Belgica
|
February 28, 2021
Tolvaptan reduces the required amount of albumin infusion in patients with decompensated cirrhosis with uncontrolled ascites : a multicenter retrospective propensity score-matched cohort study
Y Suzuki, A Naganuma, T Hoshino, et al.
ESMO Open
|
October 8, 2022
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis
M Rimini, L Rimassa, K Ueshima, et al.
Page
of 12